These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 16643576)

  • 1. Factors influencing migraineur-consulting behavior in a university population.
    Skomo ML; Desselle SP; Berdine HJ
    Headache; 2006 May; 46(5):742-9. PubMed ID: 16643576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pharmacist interventions on seeking of medical care by migraineurs.
    Skomo ML; Desselle SP; Berdine HJ; O'Neil CK
    J Am Pharm Assoc (2003); 2008; 48(1):32-7; quiz 1-4. PubMed ID: 18192128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting disability and quality of life in a community-based sample of women with migraine headache.
    Kolotylo CJ; Broome ME
    Pain Manag Nurs; 2000 Dec; 1(4):139-51. PubMed ID: 11709867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
    De Diego EV; Lanteri-Minet M
    Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "repeater" phenomenon in migraine patients: a clinical and psychometric study.
    Villani V; Di Stani F; Vanacore N; Scattoni L; Cerbo R; Bruti G
    Headache; 2010 Mar; 50(3):348-56. PubMed ID: 20039961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey.
    Lucas C; Géraud G; Valade D; Chautard MH; Lantéri-Minet M
    Headache; 2006 May; 46(5):715-25. PubMed ID: 16643573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of adherence to triptans: factors of sustained vs lapsed users.
    Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
    Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GRIM2005 study of migraine consultation in France I. Determinants of consultation for migraine headache in France.
    Lantéri-Minet M; Massiou H; Nachit-Ouinekh F; Lucas C; Pradalier A; Radat F; Mercier F; El Hasnaoui A
    Cephalalgia; 2007 Dec; 27(12):1386-97. PubMed ID: 17888013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of general practitioners' personal knowledge on migraine in medical attitudes towards their patients suffering from migraine].
    Weber M; Daurès JP; Fabre N; Druais PL; Dardenne J; Slama A; El Hasnaoui A
    Rev Neurol (Paris); 2002 Apr; 158(4):439-45. PubMed ID: 11984486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and anxiety: effect on the migraine-obesity relationship.
    Tietjen GE; Peterlin BL; Brandes JL; Hafeez F; Hutchinson S; Martin VT; Dafer RM; Aurora SK; Stein MR; Herial NA; Utley C; White L; Khuder SA
    Headache; 2007 Jun; 47(6):866-75. PubMed ID: 17578537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and overuse of antimigraine drugs by pharmacy personnel in France: COTA survey.
    Donnet A; Lantéri-Minet M; Aucoin F; Allaf B
    Headache; 2009 Jul; 49(7):1014-21. PubMed ID: 19486362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beliefs about medicines and adherence among Swedish migraineurs.
    Hedenrud T; Jonsson P; Linde M
    Ann Pharmacother; 2008 Jan; 42(1):39-45. PubMed ID: 18073328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's issues of migraine in tertiary care.
    Kelman L
    Headache; 2004 Jan; 44(1):2-7. PubMed ID: 14979877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries.
    Morillo LE; Alarcon F; Aranaga N; Aulet S; Chapman E; Conterno L; Estevez E; Garcia-Pedroza F; Garrido J; Macias-Islas M; Monzillo P; Nunez L; Plascencia N; Rodriguez C; Takeuchi Y;
    Headache; 2005 Feb; 45(2):118-26. PubMed ID: 15705116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of migraine after a 10-year follow-up.
    Nachit-Ouinekh F; Dartigues JF; Chrysostome V; Henry P; Sourgen C; El Hasnaoui A
    Headache; 2005; 45(10):1280-7. PubMed ID: 16324159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of intensive patient education on clinical outcome in a clinic-based migraine population.
    Rothrock JF; Parada VA; Sims C; Key K; Walters NS; Zweifler RM
    Headache; 2006 May; 46(5):726-31. PubMed ID: 16643574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine changes with age: IMPACT on migraine classification.
    Kelman L
    Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migraine is associated with menorrhagia and endometriosis.
    Tietjen GE; Conway A; Utley C; Gunning WT; Herial NA
    Headache; 2006 Mar; 46(3):422-8. PubMed ID: 16618258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.